Pembrolizumab induced acute corneal toxicity after allogeneic stem cell transplantation

Clin Exp Ophthalmol. 2018 Aug;46(6):698-700. doi: 10.1111/ceo.13139. Epub 2018 Feb 6.

Authors

Chia-Chieh Hsiao¹, Ming Yao², Jia-Hau Liu², Wei-Li Chen^{1

3}

Affiliations

¹ Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
² Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
³ Center of Corneal Tissue Engineering and Stem Cell Biology, National Taiwan University Hospital, Taipei, Taiwan.

PMID: 29280537
DOI: 10.1111/ceo.13139

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Disease
Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents, Immunological / adverse effects
Antineoplastic Agents, Immunological / therapeutic use
Cornea / drug effects*
Cornea / pathology
Corneal Diseases / chemically induced*
Corneal Diseases / diagnosis
Epithelium, Corneal / drug effects
Epithelium, Corneal / pathology
Female
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute / therapy
Male
Microscopy, Confocal
Slit Lamp Microscopy
Young Adult

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab